Fox News Faces Lawsuit Over Its Coronavirus Coverage
Louis DeJoy orchestrated an illegal straw donor scheme to help elect Republicans, according to a complaint filed by CREW.
Moderna and Pfizer Reveal Secret Blueprints for Coronavirus Vaccine Trials By Denise Grady and Katie Thomas Sept. 17, 2020Updated 7:26 p.m. ET
Two drug companies that are leading the race to develop coronavirus vaccines bowed to public pressure on Thursday, abandoning their traditional secrecy and releasing comprehensive road maps of how they are evaluating their vaccines.
The companies, Moderna and Pfizer, revealed details about how participants are being selected and monitored, the conditions under which the trials could be stopped early if there were problems, and the evidence researchers will use to determine whether people who got the vaccines were protected from Covid-19.
Moderna’s study will involve 30,000 participants, and Pfizer’s 44,000.
Companies typically share these documents after their studies are complete. The disclosures while the trials are still underway, a rare move, are aimed at addressing growing suspicion among Americans that President Trump’s drive to produce a vaccine before the election on Nov. 3 could result in a product that was unsafe.
The plan released by Moderna on Thursday morning included a likely timetable that could reach into next year for determining whether its vaccine works. It does not jibe with the president’s optimistic predictions of a vaccine widely available to the public in October.
Pfizer’s plan does not appear to estimate when its results could be available. Its chief executive has said repeatedly that the company hopes to have an answer as early as October. Moderna has said only that it could have a result before the end of the year.
< – >
C.D.C. Testing Guidance Was Published Against Scientists’ Objections
A controversial guideline saying people without Covid-19 symptoms didn’t need to get tested for the virus came from H.H.S. officials and skipped the C.D.C.’s scientific review process. By Apoorva Mandavilli Sept. 17, 2020Updated 8:44 p.m. ET
A heavily criticized recommendation from the Centers for Disease Control and Prevention last month about who should be tested for the coronavirus was not written by C.D.C. scientists and was posted to the agency’s website despite their serious objections, according to several people familiar with the matter as well as internal documents obtained by The New York Times.
The guidance said it was not necessary to test people without symptoms of Covid-19 even if they had been exposed to the virus. It came at a time when public health experts were pushing for more testing rather than less, and administration officials told The Times that the document was a C.D.C. product and had been revised with input from the agency’s director, Dr. Robert Redfield.
But officials told The Times this week that the Department of Health and Human Services did the rewriting and then “dropped” it into the C.D.C.’s public website, flouting the agency’s strict scientific review process.
“That was a doc that came from the top down, from the H.H.S. and the task force,” said a federal official with knowledge of the matter, referring to the White House task force on the coronavirus. “That policy does not reflect what many people at the C.D.C. feel should be the policy.”
The document contains “elementary errors” — such as referring to “testing for Covid-19,” as opposed to testing for the virus that causes it — and recommendations inconsistent with the C.D.C.’s stance that mark it to anyone in the know as not having been written by agency scientists, according to a senior C.D.C. scientist who spoke on the condition of anonymity because of a fear of repercussions.
< – >